Curoverse

Based in the United States, Curoverse is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Curoverse develops Arvados, an open source platform that enables research institutions, IT teams, and clinical labs to manage, process, analyze, and share large-scale biomedical data sets including genomics and imaging data, with flexible deployment on cloud or on-premise infrastructure.